218 related articles for article (PubMed ID: 34353406)
21. Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.
Serafini A; Gerard E; Genton P; Crespel A; Gelisse P
CNS Drugs; 2019 Mar; 33(3):195-208. PubMed ID: 30747367
[TBL] [Abstract][Full Text] [Related]
22. Evolution of antiseizure medication use and cost in the United States of America 2006-2021.
Sánchez Fernández I; Gaínza-Lein M; Amengual-Gual M; Barcia Aguilar C; Romeu A; Torres A; Jonas R; Douglass LM
Seizure; 2023 Nov; 112():128-138. PubMed ID: 37832279
[TBL] [Abstract][Full Text] [Related]
23. Pregnancy, antiseizure medications and unexplained intrauterine foetal death.
Vajda FJE; O'Brien TJ; Graham JE; Hitchcock AE; Perucca P; Lander CM; Eadie MJ
Epilepsy Behav; 2024 Apr; 153():109724. PubMed ID: 38442517
[TBL] [Abstract][Full Text] [Related]
24. Seizure control during pregnancy and postpartum period in women with epilepsy: an Egyptian prospective study.
Hosny H; Al Kattan MM; Zaki MA; Ramzy GM; Al-Azayem SA; Magdy R
BMC Neurol; 2023 Feb; 23(1):54. PubMed ID: 36732706
[TBL] [Abstract][Full Text] [Related]
25. Folic acid use by women with epilepsy: Findings of the Epilepsy Birth Control Registry.
Herzog AG; MacEachern DB; Mandle HB; Cahill KE; Fowler KM; Davis AR; Allen Hauser W
Epilepsy Behav; 2017 Jul; 72():156-160. PubMed ID: 28605689
[TBL] [Abstract][Full Text] [Related]
26. [Medical Treatment of Epilepsy].
Jin K
Brain Nerve; 2023 Apr; 75(4):347-351. PubMed ID: 37037506
[TBL] [Abstract][Full Text] [Related]
27. Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP).
Thomas SV; Jeemon P; Pillai R; Jose M; Lalithakumari AM; Murali S; Sanalkumar A; Salini RA; Pavithran V
Seizure; 2021 Dec; 93():127-132. PubMed ID: 34740142
[TBL] [Abstract][Full Text] [Related]
28. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry.
EURAP Study Group
Neurology; 2006 Feb; 66(3):354-60. PubMed ID: 16382034
[TBL] [Abstract][Full Text] [Related]
29. Real-world practices for the care of women with epilepsy during pregnancy: A Canadian perspective.
Fantaneanu TA; Thornton HF; Zhang T; Bercovici E; Hrazdil C; Ikeda KM; Kassiri J; Suller Marti A; Pana R; Rezazadeh A; Kobayashi E; Bui E;
Epilepsy Behav; 2023 Nov; 148():109468. PubMed ID: 37857032
[TBL] [Abstract][Full Text] [Related]
30. Pregnancy and Epilepsy: a Korean Tertiary Epilepsy Center Review.
Jeon JY; Bae JG; Kim KT; Cho YW
J Korean Med Sci; 2020 May; 35(19):e119. PubMed ID: 32419394
[TBL] [Abstract][Full Text] [Related]
31. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy.
Reisinger TL; Newman M; Loring DW; Pennell PB; Meador KJ
Epilepsy Behav; 2013 Oct; 29(1):13-8. PubMed ID: 23911354
[TBL] [Abstract][Full Text] [Related]
32. Epileptic seizure control during and after pregnancy in Australian women.
Vajda FJE; O'Brien TJ; Graham JE; Hitchcock AA; Perucca P; Lander CM; Eadie MJ
Acta Neurol Scand; 2022 Jun; 145(6):730-736. PubMed ID: 35257362
[TBL] [Abstract][Full Text] [Related]
33. Risk of sudden unexpected death in epilepsy (SUDEP) with lamotrigine and other sodium channel-modulating antiseizure medications.
Nightscales R; Barnard S; Laze J; Chen Z; Tao G; Auvrez C; Sivathamboo S; Cook MJ; Kwan P; Friedman D; Berkovic SF; D'Souza W; Perucca P; Devinsky O; O'Brien TJ
Epilepsia Open; 2023 Jun; 8(2):334-345. PubMed ID: 36648376
[TBL] [Abstract][Full Text] [Related]
34. Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018.
Yu L; Feng J; Yu Z; Dai H
Epilepsy Res; 2020 Nov; 167():106448. PubMed ID: 32916644
[TBL] [Abstract][Full Text] [Related]
35. Predicting epileptic seizure control during pregnancy.
Vajda FJE; O'Brien TJ; Graham JE; Hitchcock AA; Lander CM; Eadie MJ
Epilepsy Behav; 2018 Jan; 78():91-95. PubMed ID: 29179105
[TBL] [Abstract][Full Text] [Related]
36. Patterns of antiseizure medication utilization in the Human Epilepsy Project.
Fox J; Barnard S; Agashe SH; Holmes MG; Gidal B; Klein P; Abou-Khalil BW; French J;
Epilepsia; 2023 Dec; 64(12):3196-3204. PubMed ID: 37846772
[TBL] [Abstract][Full Text] [Related]
37. Correlation of drug dose estimated from national prescription registers with mean blood level of antiseizure medication in pregnancy.
Christensen J; Trabjerg B; Dreier JW
Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5811. PubMed ID: 38783423
[TBL] [Abstract][Full Text] [Related]
38. Levetiracetam use during pregnancy in women with epilepsy: Preliminary observations from a tertiary care center in Northern India.
Bansal R; Suri V; Chopra S; Aggarwal N; Sikka P; Saha SC; Goyal MK; Kumar P
Indian J Pharmacol; 2018; 50(1):39-43. PubMed ID: 29861526
[TBL] [Abstract][Full Text] [Related]
39. Second antiseizure medication monotherapy in patients with adult-onset epilepsy: A register-based analysis.
Polychronidis K; Håkansson S; Hosseini Ashtiani S; Idegård A; Larsson D; Zelano J
Epilepsy Behav; 2024 Jun; 155():109792. PubMed ID: 38669974
[TBL] [Abstract][Full Text] [Related]
40. Twenty-year trends in the use of anti-seizure medication among pregnant women in the Netherlands.
Houben E; Benson RJ; Steegers EAP; Herings RMC
Epilepsy Behav; 2022 Feb; 127():108549. PubMed ID: 35042161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
